Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myeloma
Abstract Despite advances in treatments, multiple myeloma (MM) remains an incurable cancer where relapse is common. We developed a circulating tumor DNA (ctDNA) approach in order to characterize tumor genomics, monitor treatment response, and detect early relapse in MM. By sequencing 412 specimens f...
Saved in:
| Main Authors: | Hitomi Hosoya, Mia Carleton, Kailee Tanaka, Brian Sworder, Shriya Syal, Bita Sahaf, Alisha M. Maltos, Oscar Silva, Henning Stehr, Vanna Hovanky, George Duran, Tian Zhang, Michaela Liedtke, Sally Arai, David Iberri, David Miklos, Michael S. Khodadoust, Surbhi Sidana, David M. Kurtz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-56486-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
by: Crystal Mackall, et al.
Published: (2024-07-01) -
Real time machine learning prediction of next generation sequencing test results in live clinical settings
by: Grace Y. E. Kim, et al.
Published: (2025-08-01) -
Ideas para un banco de ideas
by: Werner Stehr Wilckens
Published: (2000-08-01) -
Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myeloma
by: Danai Dima, et al.
Published: (2025-07-01) -
Saluto Istituzionale. La fede, la vita, l’educazione
by: Vanna Boffo
Published: (2024-07-01)